Onderneming Calmare Therapeutics Incorporated Other OTC
Aandelen
CTTC
US13126R1023
Geavanceerde medische apparatuur & technologie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 27-09-13 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 01-10-07 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 27-09-13 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 06-06-11 |
Santanu Das
BRD | Director/Board Member | - | 12-07-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 997 971 | 38 997 971 ( 100,00 %) | 0 | 99,99 % |
Aandeel B | 0 | 2 427 | 0 | 0 |
Bedrijfsgegevens
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.com![Adres Calmare Therapeutics Incorporated(CTTC)](https://cdn.zonebourse.com/static/address/23689346.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,18% | 211 mld. | |
+8,00% | 185 mld. | |
+31,86% | 158 mld. | |
+33,21% | 113 mld. | |
+2,28% | 64,32 mld. | |
+21,14% | 55,66 mld. | |
+0,11% | 48,41 mld. | |
-6,76% | 37,82 mld. | |
+0,78% | 35,57 mld. |